Described herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate prescription drugs, such methods including a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very lower permeability to oxygen and compris